Evidence map›Paper›PMID 29610477›Full record

ArticleNature genetics2018

Switching from fetal to adult hemoglobin.

Xunde Wang, Swee Lay Thein

Registry-linked trialAbstract readComment
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04432623 (A Phase 1b Sequential Open Label Dose-Ranging Study of Safety, Pharmacokinetics, and Preliminary Activity of Benserazide in Subjects With Beta Thalassemia Intermedia and Sickle Cell Disease), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04432623 phase1 / phase2enrolling by invitationnot on this mapstarted 2020, after this paper: background citation

A Phase 1b Sequential Open Label Dose-Ranging Study of Safety, Pharmacokinetics, and Preliminary Activity of Benserazide in Subjects With Beta Thalassemia Intermedia and Sickle Cell Disease

TypeinterventionalSponsorPhoenicia BioScienceRan2020 to 2026Enrolled36ConditionsBeta Thalassemia Intermedia, Sickle Cell DiseaseArmsBenserazide Only Product
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Evolution of the Umbilical Cord Blood Proteome Across Gestational Development.medRxiv : the preprint server for health sciences · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Role of Nuclear Receptors in Controlling Erythropoiesis.International journal of molecular sciences · 2022
    Review
  15. Transmembrane Protein ANTXR1 RegulatesJournal of immunology research · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Xunde WangNational Heart, Lung and Blood Institute/NIH, Sickle Cell Branch, Bethesda, MD, USA.
Swee Lay TheinNational Heart, Lung and Blood Institute/NIH, Sickle Cell Branch, Bethesda, MD, USA. sl.thein@nih.gov.

Funding

Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA-Binding ProteinsTranscription FactorsAdultCell Line, TumorHemoglobinsHumansMutationDNA-Binding ProteinsHemoglobinsTranscription Factors

Identifiers

PMID29610477
PMCPMC6419756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.